Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Eye drop

A technology of eye drops and vitamins, which is applied in the field of medicine, can solve the problems of eye damage, aggravation of eye diseases, and aggravation of eye burden, and achieve the effect of convenient use and remarkable therapeutic effect

Inactive Publication Date: 2017-04-26
青岛益邦瑞达生物科技有限公司
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Eyes are the window of the soul, an important organ that enables people to communicate with this society. However, with the development of high technology, people's lives are becoming more and more diverse, but they use their eyes more frequently. During leisure, electronic products are in people's life all the time, which increases the burden on the eyes. Modern people have frequent eye diseases, which can be caused by various reasons, but facing computers and mobile phones for a long time is the most direct cause of frequent eye diseases. Factors, medically, eye diseases are divided into internal and external eye diseases. There are many eye drops for eye diseases on the market. The dosage is very small, and a small amount of use will not cause damage to the eyes, but long-term use will not relieve eye fatigue and improve eye diseases, but may damage the eyes and aggravate eye diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0011] An eye drop, which is composed of the following raw materials in parts by weight: 15 parts of pearl liquid, 5 parts of taurine, 8 parts of vitamins, 5 parts of aspartic acid, 10 parts of cassia seeds, 5 parts of orange peel, and 5 parts of heparin calcium , 3 parts of mulberry liquid, 3 parts of Polygonum multiflorum, 5 parts of green tea extract, 3 parts of animal dirty extract, 5 parts of ginseng extract, 10 parts of borneol, and 3 parts of antibiotics.

[0012] Further, in the above-mentioned eye drops, the vitamins are vitamin B6 and vitamin A, and the antibiotic is ribomycin.

Embodiment 2

[0014] An eye drop, which is composed of the following raw materials in parts by weight: 20 parts of pearl liquid, 8 parts of taurine, 10 parts of vitamins, 10 parts of aspartic acid, 15 parts of cassia seeds, 8 parts of orange peel, and 10 parts of heparin calcium , 5 parts of mulberry liquid, 5 parts of Polygonum multiflorum, 8 parts of green tea extract, 5 parts of animal dirty extract, 8 parts of ginseng extract, 15 parts of borneol, and 5 parts of antibiotics.

[0015] Further, in the above-mentioned eye drops, the vitamins are vitamin B6 and vitamin A, and the antibiotic is ribomycin.

Embodiment 3

[0017] An eye drop, which is composed of the following raw materials in weight fractions: 18 parts of pearl liquid, 7 parts of taurine, 9 parts of vitamins, 8 parts of aspartic acid, 12 parts of cassia seeds, 6 parts of orange peel, and 8 parts of heparin calcium , 4 parts of mulberry liquid, 4 parts of Polygonum multiflorum, 7 parts of green tea extract, 4 parts of animal dirty extract, 6 parts of ginseng extract, 12 parts of borneol, and 4 parts of antibiotics.

[0018] Further, in the above-mentioned eye drops, the vitamins are vitamin B6 and vitamin A, and the antibiotic is ribomycin.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medicines, and concretely relates to an eye drop. The eye drop comprises, by weight, 15-20 parts of a pearl liquid, 5-8 parts of taurine, 8-10 parts of vitamins, 5-10 parts of aspartic acid, 10-15 parts of Semen Cassiae, 5-8 parts of orange peel, 5-10 parts of heparin calcium, 3-5 parts of a mulberry liquid, 3-5 parts of Polygonum multiflorum, 5-8 parts of a green tea extract liquid, 3-5 parts of an animal internal organ extract liquid, 5-8 parts of a ginseng extract liquid, 10-15 parts of borneol and 3-5 parts of antibiotics. The raw materials of the eye drop are most from natural plants and Chinese herbal medicines, and no antiseptics, hormones or other substances harmful to human bodies are added, so the eye drop has the advantages of no dependence of people, substantial treatment effect, and convenience and comfortableness in use.

Description

technical field [0001] The invention relates to the technical field of medicines, in particular to eye drops. Background technique [0002] Eyes are the window of the soul, an important organ that enables people to communicate with this society. However, with the development of high technology, people's lives are becoming more and more diverse, but they use their eyes more frequently. During leisure, electronic products are in people's life all the time, which increases the burden on the eyes. Modern people have frequent eye diseases, which can be caused by various reasons, but facing computers and mobile phones for a long time is the most direct cause of frequent eye diseases. Factors, medically, eye diseases are divided into internal and external eye diseases. Now there are many eye drops for eye diseases on the market. The dosage is very small, and a small amount of use will not cause damage to the eyes, but long-term use will not relieve eye fatigue and improve eye dise...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/82A61P27/02A61K31/045A61K31/185A61K31/198A61K31/727A61K35/618
Inventor 于桂菊
Owner 青岛益邦瑞达生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products